 |
 

 |
 |
 |

"Just another face in the
crowd? An fMRI study of amygdala response to schematic faces
in social anxiety disorder"
February 6, 2007
|
Karleyton C. Evans, MD
Instructor in Psychiatry, Psychiatric
Neuroscience Division, MGH
Karleyton C. Evans, MD, MS, is
a member of the clinical research staff of the Psychiatric Neuroscience
Research and Neurotherapeutics Division at the Massachusetts General
Hospital (MGH) and an Instructor of Psychiatry at Harvard Medical
School (HMS). Dr. Evans received his MD from Dartmouth Medical
School and completed his residency in psychiatry at the combined
MGH/McLean Psychiatry Residency Training Program. His current
research encompasses neuroimaging projects that investigate the
pathophysiology and treatment of depression and anxiety with a
focus on panic and social anxiety disorders. As a complement to
Dr. Evans' major clinical and research efforts, he holds particular
scientific interest and expertise in the neuroimaging of respiratory
and autonomic stress responses. Dr.
Evans has received fellowship awards from the American Psychiatric
Institute for Research and Education, as well as the Clinical
Investigator Training Program sponsored by HMS, The Massachusetts
Institute of Technology, The Beth Israel/Deaconess Medical Center
and Pfizer, Inc. Dr. Evans
is also a recipient of the MGH Physician-Scientist Development
Award (2004), sponsored by the Multicultural Affairs Office (MAO).
His MGH-MAO sponsored study employs a novel approach to studying
the neural circuitry underlying panic disorder and promises to
identify candidate neural targets that may guide the development
of future treatments for the disorder.
|
|
"Linking genetic
alterations to 'target-able' tumor dependencies in human cancer."
December 12,
2006 |
Levi Garraway, M.D., Ph.D.
Instructor, Medical Oncology, Dana Farber Cancer Institute
Levi A. Garraway received his A.B.
in Biochemical Sciences from Harvard College in 1990, and his
M.D. and Ph.D. degrees from Harvard Medical School in 1999. Thereafter,
he completed his internship and residency in Internal Medicine
at the Massachusetts General Hospital, where he also served as
Medical Chief Resident in 2003. Dr. Garraway received fellowship
training in Medical Oncology at the Dana-Farber Cancer Institute.
He now holds a faculty appointment at the Dana-Farber Cancer Institute
and Harvard Medical School, where his research involves integrated
and functional genomic studies of melanoma. He is also an Associate
Member of the Broad Institute of Harvard and MIT. Dr. Garraway
has been the recipient of several awards and honors, including
the Minority Scholar Award from the American Association of Cancer
Research, the Partners in Excellence Award from the Massachusetts
General Hospital, and the Career Award in the Biomedical Sciences
from the Burroughs-Welcome Fund.
|
|

"New Directions
in Phosphate and Vitamin D Biology"
October 19,
2006
|
Sherri-Ann M. Burnett-Bowie,
MD, MPH
Instructor in Medicine
Endocrine Unit, MGH
Sherri-Ann
M. Burnett-Bowie received her A.B. in Biochemical Sciences from
Harvard College in 1993, M.D. from the University of Pittsburgh
School of Medicine in 1997 and M.P.H. degree from the Harvard
School of Public Health in 2005. She completed her residency in
Internal Medicine and fellowship in Endocrinology at Massachusetts
General Hospital. Dr. Burnett-Bowie holds a faculty appointment
as Instructor in Medicine at MGH. In 2005, Dr. Burnett-Bowie was
awarded the MGH Physician-Scientist Development Award. Her research
focuses on phosphate and Vitamin D biology, and clinical trials
for osteoporosis. Dr. Burnett-Bowie was recently awarded a K23
NIH grant for ongoing research on the dietary and hormonal regulation
of FGF-23 in humans.
|
|

"Genetic Predictors
of Type 2 Diabetes"
June 6, 2006 |
Jose C. Florez, M.D., Ph.D.
Instructor, Harvard Medical School
Clinical Assistant in Endocrinology, Diabetes Unit
Research Fellow in Molecular Biology
Jose C. Florez, MD, Ph graduated
from the combined B.A./M.S. Honors Program at Northwestern University
in 1988 and then entered the Medical Scientist Training Program
at Northwestern University . After obtaining M.D./Ph.D. degrees,
Dr. Florez moved to Boston in 1997 where he had matched as a preliminary
medical intern at the Massachusetts General Hospital. After one
year in the combined Partners Neurology program, he returned to
the internal medicine residency at MGH and completed fellowship
training in endocrinology. Since 2002 he has been working with
David Altshuler on the genetics of type 2 diabetes, with particular
attention to genes that encode hypoglycemic drug targets. Currently,
Dr. Florez is an Instructor at Harvard Medical School and Clinical
Assistant in the Diabetes Unit at the Massachusetts General Hospital.
|
|

"The Emergency
Medicine Network - Advancing Public Health Goals through the Emergency
Department"
April 4, 2006
|
Carlos A. Camargo, MD, DrPH
Director, EMNet Coordinating Center
Massachusetts General Hospital
Carlos A. Camargo, MD,
MPH, DrPH, is an Associate Professor of Medicine and Epidemiology
at Harvard Medical School, an emergency physician at Massachusetts
General Hospital, and a research epidemiologist at the Channing
Laboratory, Brigham and Women's Hospital - all in Boston. He chairs
the Steering Committee of the Emergency
Medicine Network (EMNet), a research collaboration with 185
emergency departments. His also focuses on asthma/COPD in several
large national cohorts (e.g., the Nurses' Health Studies). Dr
Camargo is Past President of the American College of Epidemiology
and recently served on the 2005 U.S. Dietary Guidelines Advisory
Committee. He currently serves on the NIH's National Asthma Education
and Prevention Program's Third Expert Panel (the group writing
the 2006 US asthma guidelines) and on two US Institute of Medicine
committees: one on occupational health research, the other on
nutritional standards for food in schools. He has over 200 peer-reviewed
publications. Dr. Camargo received his MD from the University
of California, San Francisco; MPH from the University of California,
Berkeley; and DrPH from the Harvard School of Public Health.
|
|

"Understanding
Barriers to Cervical Cancer Screening Among Latino Women in Boston"
February 7,
2006 |
Marcela Del Carmen, M.D.
Assistant Professor, Harvard Medical School;
Gynecologic Oncology, at the MGH Cancer Center
Received her B.S. from Emory University,
Atlanta, GA, in 1991 and Medical degree from Johns Hopkins University
School of Medicine in 1995. Currently working on her Masters in
Public Health from the Harvard School of Public Health. In 2002,
when completed her fellowship at MGH, Marcela left to go back
to Johns Hopkins as an Assistant Professor, Department of Gynecology
and Obstetrics, but a few years later, in 2003, we managed to
recruit her back as an Assistant Professor in the Dept of Obstetrics
and Gynecology at MGH.Winner of numerous awards for her outstanding
performance as a surgeon and teacher. Most recently, she is the
recipient of the MGH Clinician-Teacher Development Award, an career
development award sponsored by MAO, the President's Office and
MGPO, for Dr. del Carmen to embark in an educational and community
project to advance as a clinician-teacher at MGH and HMS. Her
current research interestes focus on understanding barriers to
Cervical Cancer screening in the Latina population being served
by MGH.
|
Please see our new Calendar of Events for future
meeting times. |
 |
 |